$8.10
0.060.75%
Pre-Market: 7:08 AM EDT
Comments
Loading...
Arvinas Insider Trading Activity | NASDAQ:ARVN | Benzinga
Track the latest Arvinas insider trading activity. Stay informed on recent buys, sells, and market impact for Arvinas stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Arvinas Inc Insiders Doing?
At Arvinas Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 8.66K shares worth $74.37K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 25, 2025, David K Loomis, the company's CHIEF ACCOUNTING OFFICER sold 1.21K shares for $16.75 each.
- On February 25, 2025, Angela M Cacace, the company's CHIEF SCIENTIFIC OFFICER sold 4.21K shares for $16.7 each.
- On March 18, 2025, Noah Berkowitz, the company's CHIEF MEDICAL OFFICER sold 8.66K shares for $8.59 each.
Ownership Statistics for Arvinas Inc
Shares Outstanding
68.772M
Insider Shares Owned
2.336M
Insider Percentage Owned
3.40%
Institutional Shares Held
37.402M
Institutional Percentage Held
54.4%
| Mar 19, 2025 | Noah Berkowitz | CHIEF MEDICAL OFFICER | -8.66K | $8.59 | -$74.37K | SELL | -7.30% | 110.02K | Mar 18 | View |
| Feb 25, 2025 | David K Loomis | CHIEF ACCOUNTING OFFICER | -1.21K | $16.75 | -$20.33K | SELL | -6.05% | 18.86K | Feb 24 | View |
| Feb 25, 2025 | Angela M Cacace | CHIEF SCIENTIFIC OFFICER | -4.21K | $16.70 | -$70.24K | SELL | -4.15% | 97.23K | Feb 24 | View |
| Feb 25, 2025 | Ian Taylor | PRESIDENT, R&D | -9.02K | $16.71 | -$150.75K | SELL | -5.36% | 159.12K | Feb 24 | View |
| Feb 25, 2025 | John Houston | PRESIDENT AND CEO | -31.34K | $16.72 | -$523.88K | SELL | -2.64% | 1.16M | Feb 24 | View |
| Nov 12, 2024 | David K Loomis | CHIEF ACCOUNTING OFFICER | -460.00 | $22.39 | -$10.30K | SELL | -5.41% | 8.04K | Nov 08 - Nov 07 | View |
| Feb 27, 2024 | John Houston | PRESIDENT AND CEO | 119.25K | $47.05 | -$244.47K | GRANT | 13.00% | 1.04M | Feb 23 | View |
| Feb 27, 2024 | Sean A Cassidy | CHIEF FINANCIAL OFFICER | -1.70K | $47.05 | -$80.08K | SELL | -0.93% | 181.92K | Feb 23 | View |
| Feb 27, 2024 | Ronald Peck | CHIEF MEDICAL OFFICER | 37.55K | $47.05 | -$79.94K | GRANT | 125.32% | 67.52K | Feb 23 | View |
| Feb 27, 2024 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 37.55K | $47.05 | -$80.03K | GRANT | 34.14% | 147.52K | Feb 23 | View |
| Aug 14, 2023 | Ronald Peck | CHIEF MEDICAL OFFICER | 2.69K | $24.39 | -$32.29K | SELL-OPTIONS | 9.85% | 29.96K | Aug 11 | View |
| Mar 03, 2023 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 1.63K | $29.53 | -$31.04K | SELL-OPTIONS | 1.63% | 101.72K | Mar 01 | View |
| Mar 03, 2023 | John G Houston | PRESIDENT AND CEO | 11.63K | $29.53 | -$173.58K | SELL-OPTIONS | 1.28% | 917.43K | Mar 01 | View |
| Mar 03, 2023 | Sean Cassidy | CHIEF FINANCIAL OFFICER | 3.05K | $29.53 | -$51.53K | SELL-OPTIONS | 1.69% | 183.62K | Mar 01 | View |
| Aug 16, 2022 | Ronald Peck | CHIEF MEDICAL OFFICER | 2.75K | $68.99 | -$86.79K | SELL-OPTIONS | 50.94% | 8.15K | Aug 12 | View |
| Apr 18, 2022 | Briggs Morrison | DIRECTOR | -4.77K | $41.22 | -$1.13M | SELL | -19.28% | 19.98K | Apr 14 | View |
| Mar 15, 2022 | Sean A Cassidy | CHIEF FINANCIAL OFFICER | 0.00 | $43.00 | -$810.00K | SELL-OPTIONS | 0.00% | 161.45K | Mar 11 | View |
| Mar 04, 2022 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 1.82K | $63.94 | -$55.56K | SELL-OPTIONS | 2.21% | 83.96K | Mar 04 | View |
| Mar 04, 2022 | Sean Cassidy | CHIEF FINANCIAL OFFICER | 3.20K | $63.94 | -$101.86K | SELL-OPTIONS | 2.02% | 161.45K | Mar 04 | View |
| Mar 04, 2022 | John Houston | PRESIDENT AND CEO | 11.49K | $63.94 | -$385.17K | SELL-OPTIONS | 1.38% | 843.82K | Mar 04 | View |
| Feb 17, 2022 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 0.00 | $46.19 | -$1.07M | SELL-OPTIONS | 0.00% | 78.64K | Feb 15 | View |
| Jan 19, 2022 | Briggs Morrison | DIRECTOR | -4.77K | $40.78 | -$1.12M | SELL | -16.17% | 24.75K | Jan 14 | View |
| Jan 04, 2022 | Ronald Peck | CHIEF MEDICAL OFFICER | 0.00 | $61.07 | -$781.66K | SELL-OPTIONS | 0.00% | 5.40K | Dec 30 | View |
| Dec 21, 2021 | Sean Cassidy | CHIEF FINANCIAL OFFICER | 0.00 | $43.00 | -$810.00K | SELL-OPTIONS | 0.00% | 158.25K | Dec 17 | View |
| Dec 16, 2021 | Liam Ratcliffe | DIRECTOR | -355.70K | $67.00 | -$23.83M | SELL | -65.70% | 185.69K | Dec 14 - Dec 16 | View |
| Nov 17, 2021 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 0.00 | $50.67 | -$1.33M | SELL-OPTIONS | 0.00% | 78.64K | Nov 15 | View |
| Nov 15, 2021 | Liam Ratcliffe | DIRECTOR | -134.31K | $85.83 | -$11.53M | SELL | -19.88% | 541.39K | Nov 10 - Nov 15 | View |
| Nov 09, 2021 | Liam Ratcliffe | DIRECTOR | -153.66K | $61.29 | -$15.46M | SELL | -18.53% | 675.70K | Nov 05 - Nov 09 | View |
| Nov 03, 2021 | John G Houston | PRESIDENT AND CEO | 0.00 | $52.07 | -$2.89M | SELL-OPTIONS | 0.00% | 832.33K | Nov 01 | View |
| Sep 27, 2021 | Timothy M Shannon | DIRECTOR | -68.80K | $87.41 | -$6.01M | SELL | -3.82% | 1.73M | Sep 03 - Sep 07 | View |
| Sep 27, 2021 | Timothy M Shannon | DIRECTOR | -190.56K | $86.25 | -$16.44M | SELL | -9.56% | 1.80M | Aug 31 - Sep 02 | View |
| Sep 27, 2021 | Timothy M Shannon | DIRECTOR | -115.58K | $85.72 | -$9.91M | SELL | -5.48% | 1.99M | Aug 26 - Aug 30 | View |
| Sep 27, 2021 | Timothy M Shannon | DIRECTOR | -25.07K | $85.95 | -$2.15M | SELL | -1.17% | 2.11M | Aug 23 - Aug 25 | View |
| Aug 27, 2021 | Bradley Albert Margus | DIRECTOR | -29.94K | $85.01 | -$2.55M | SELL | -32.76% | 61.46K | Aug 25 - Aug 26 | View |
| Aug 18, 2021 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 0.00 | $51.65 | -$1.43M | SELL-OPTIONS | 0.00% | 78.64K | Aug 16 | View |
| Aug 16, 2021 | Ronald Peck | CHIEF MEDICAL OFFICER | 2.65K | $90.54 | -$123.40K | SELL-OPTIONS | 96.15% | 5.40K | Aug 12 | View |
| Aug 13, 2021 | Bradley Albert Margus | DIRECTOR | -10.83K | $90.03 | -$974.84K | SELL | -10.59% | 91.40K | Aug 11 - Aug 13 | View |
| Aug 04, 2021 | John Houston | PRESIDENT AND CEO | 0.00 | $56.91 | -$3.76M | SELL-OPTIONS | 0.00% | 827.64K | Aug 02 | View |
| Jul 30, 2021 | Sean Cassidy | CHIEF FINANCIAL OFFICER | 0.00 | $58.00 | -$1.45M | SELL-OPTIONS | 0.00% | 158.25K | Jul 28 | View |
| Jul 02, 2021 | Ronald Peck | CHIEF MEDICAL OFFICER | 0.00 | $62.03 | -$586.20K | SELL-OPTIONS | 0.00% | 2.75K | Jun 30 | View |
| Jun 11, 2021 | John G Houston | PRESIDENT AND CEO | 0.00 | $48.73 | -$2.92M | SELL-OPTIONS | 0.00% | 827.64K | Jun 09 - Jun 10 | View |
| Apr 07, 2021 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 0.00 | $41.40 | -$1.27M | SELL-OPTIONS | 0.00% | 78.64K | Apr 05 | View |
| Mar 02, 2021 | Ian Taylor | CHIEF SCIENTIFIC OFFICER | 1.79K | $77.45 | -$69.24K | SELL-OPTIONS | 2.33% | 78.64K | Mar 02 | View |
| Mar 02, 2021 | Sean Cassidy | CHIEF FINANCIAL OFFICER | 2.57K | $77.45 | -$172.02K | SELL-OPTIONS | 1.65% | 158.25K | Mar 02 | View |
| Mar 02, 2021 | John G Houston | PRESIDENT AND CEO | 10.02K | $53.10 | -$610.53K | SELL-OPTIONS | 0.61% | 1.65M | Jun 30 - Mar 02 | View |
| Feb 18, 2021 | John G Houston | PRESIDENT AND CEO | 0.00 | $47.39 | -$2.76M | SELL-OPTIONS | 0.00% | 816.20K | Feb 16 | View |
| Feb 18, 2021 | Sean Cassidy | CHIEF FINANCIAL OFFICER | 0.00 | $47.23 | -$2.62M | SELL-OPTIONS | 0.00% | 154.78K | Feb 16 | View |
| Feb 18, 2021 | Ronald Peck | CHIEF MEDICAL OFFICER | 0.00 | $51.96 | -$1.02M | SELL-OPTIONS | 0.00% | 2.75K | Feb 16 | View |
| Dec 21, 2020 | Liam Ratcliffe | — | 142.86K | $70.00 | $10.00M | PURCHASE | 21.01% | 822.86K | Dec 18 | View |
| Nov 12, 2020 | Edward Moore Kennedy, Jr. | — | 8.33K | $23.99 | $199.91K | PURCHASE | 24.23% | 42.72K | Nov 09 | View |
| Aug 18, 2020 | Ronald Peck | — | 2.75K | $27.46 | -$34.49K | OPTION EXERCISE | ∞ | 2.75K | Aug 14 | View |
| Jun 19, 2020 | Timothy M Shannon | — | 2.00K | $30.26 | $60.52K | PURCHASE | 0.04% | 4.57M | Jun 17 | View |
| Jun 04, 2020 | Timothy M Shannon | — | 3.00K | $32.30 | $96.90K | PURCHASE | 0.07% | 4.57M | Jun 02 | View |
| May 14, 2020 | Sean Cassidy | — | -10.00K | $60.00 | -$600.00K | SELL | -6.23% | 150.42K | May 12 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.